SCHEMBL2363692

SCHEMBL2363692

O=C(CC/C(=N/O)OC(=O)c1cccnc1Cl)OC(=O)c1cccnc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KMT2A Q03164 6/20 0.44
MEN1 O00255 3/20 0.44
TDP1 Q9NUW8 3/20 0.43
CYP2D6 P10635 1/20 0.43
PKM P14618 1/20 0.43
AGTR1 P30556 1/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 1/20 0.42
RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2362865 0.84 NAPRT (0.45) POLBL3MBTL1CASP3SENP8SENP7
SCHEMBL2185979 0.81 P2RX7 (0.39) POLBL3MBTL1LMNASMN1; SMN2KMT2A
SCHEMBL2362641 0.81 RAB9A (0.41) POLBL3MBTL1LMNASMN1; SMN2KMT2A
SCHEMBL1566593 0.81 POLB (0.52) POLBL3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL2363363 0.75 CES2 (0.41) L3MBTL1CYP1A2CYP2C19CASP3SENP8
SCHEMBL9244293 0.73 AKR1C3 (0.44) L3MBTL1CYP1A2CYP2C9CYP2C19LMNA
SCHEMBL5195782 0.72 CYP3A4 (0.33) ALDH1A1
SCHEMBL2289029 0.72 CAPN1 (0.37) L3MBTL1LMNASMN1; SMN2KMT2AMEN1
SCHEMBL2295910 0.72 HTT (0.51) POLBL3MBTL1LMNASMN1; SMN2KMT2A
SCHEMBL2356948 0.71 PRSS1 (0.42) POLBL3MBTL1CYP2C19CASP3SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989430-B2 Antibacterial agents REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2011-08-02 US disclosed
US-20080293666-A1 Antibacterial Agents REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2008-11-27 US disclosed
EP-1960518-A2 ANTIBACTERIAL AGENTS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2008-08-27 EP disclosed
WO-2007067559-A2 ANTIBACTERIAL AGENTS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293666-A1 Antibacterial Agents MRPL21, ABCB7, MSR1 POLB 933/4885L3MBTL1 297/4885CYP1A2 1137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.